[Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation]

Popova AY, Andreeva EE, Babura EA, Balakhonov SV, Bashketova NS, Bulanov MV, Valeullina NN, Goryaev DV, Detkovskaya NN, Ezhlova EB, Zaitseva NN, Istorik OA, Kovalchuk IV, Kozlovskikh DN, Kombarova SV, Kurganova OP, Kutyrev VV, Lomovtsev AE, Lukicheva LA, Lyalina LV, Melnikova AA, Mikailova OM, Noskov AK, Noskova LN, Oglezneva EE, Osmolovskay TP, Patyashina MA, Penkovskaya NA, Samoilova LV, Smirnov VS, Stepanova TF, Trotsenko OE, Totolyan AA. [Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation]. Infektsiia Immun. 2021; 11(2): 297-323.